Library and archive

3rd Edition, Czech version (ICD-O-3 CV)

ISBN: 80-7280-373-5
Pages: ca. 293 pages
Published in 2004.

Translation of International Classification of Diseases for Oncology, 3rd Edition (English original, 2000). It presents a revised system of codes and terms used in coding the topography and the histological image (morphology) of neoplasms. It stabilises the taxonomy of neoplasms on the basis of their histopathological and biological characteristics and facilitates standardisation of nomenclature. The publication amends the previous 2nd edition. The topographic part of the 3rd edition derived from Chapter 2 of ICD-10 remains the same as in the 2nd edition. Also the codes for biological behaviour and grading have not been substantially changed. Significantly revised is the part of ICD-O-3 CV dealing with morphology. Changes concerning mainly non-Hodgkin´s type lymphomas, leukaemia and biological behaviour of some neoplasms. The rules for correct coding are also desribed in detail.

6th Edition (2002) - Czech Version (2004)

ISBN: 80-7280-391-3
Paged: ca. 196 pages
Published in 2004

Translation of TNM Classification of Malignant Tumours, 6th edition, 2002. TNM is the most widely used system of classification of the extent of cancer. The 6th edition of the TNM classification of malignant neoplasms presents new internationally approved standards for the description and categorisation of the staging and proliferation of tumours. It contains new updated organ-specific classifications in treatment of patients with tumours, for adequate classification, therapy and prognosis. Revised standards comprise: significant changes in classification of carcinoma of liver, the bile ducts, pancreas, mesothelium of pleura, bone tumours, malignant melanoma of skin, tumours of the eye and of regional lymph nodes with carcinoma of woman breast; classification of tumours of nasal cavities; changes in classification of tumours of head and neck; risk factors in tumours of trophoblast (adjusted according to recommendation of FIGO); new subcategories in classification of tumours of stomach, prostate and kidney and new division of stages of colorectal carcinoma; schemes for recording the evaluation of sentinel lymph nodes and isolated cancer cells and other changes.